This article is published in association with European Investment Bank. The European Investment Bank (EIB) is lending €100 million to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other serious conditions with few treatment options. The financing will support Orion Pharma’s research and development activities across its European centres, covering personnel […]